Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-083328

Options or other derivatives

  • Director acquired 19,657 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Machado Patrick · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-06-05 Grant or award : show line 1 in the form Share Option (Right to Buy) +17,012 17,012 D
2025-06-05 Grant or award : show line 2 in the form Restricted Share Units +2,645 2,645 D
Loading xslF345X05/ownership.xml…